25370-46-1

Basic information

• Product Name: 4-OXO-4-PYRIDIN-4-YL-BUTYRIC ACID ETHYL ESTER
• Synonyms: γ-Oxo-4-pyridinebutyric Acid Ethyl Ester;γ-oxo-4-Pyridinebutanoic Acid Ethyl Estee
• CAS NO: 25370-46-1
• Molecular Formula: C₁₁H₁₃NO₃
• Molecular Weight: 207.23
• Product Categories: Amines;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals
• Mol File: 25370-46-1.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 347.7°Cat760mmHg
• Flash Point: 164.1°C
• Appearance: /
• Density: 1.128g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.507
• PKA: 3.05±0.10(Predicted)
• CAS DataBase Reference: 4-OXO-4-PYRIDIN-4-YL-BUTYRIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-OXO-4-PYRIDIN-4-YL-BUTYRIC ACID ETHYL ESTER(25370-46-1)
• EPA Substance Registry System: 4-OXO-4-PYRIDIN-4-YL-BUTYRIC ACID ETHYL ESTER(25370-46-1)

Safety Data

• Hazardous Substances Data: 25370-46-1(Hazardous Substances Data)

Usage

Uses

γ-Pyridyl- and γ-quinolylbutyrolactones as potential anthelmintics.

InChI:InChI=1/C11H13NO3/c1-2-15-11(14)4-3-10(13)9-5-7-12-8-6-9/h5-8H,2-4H2,1H3

Upstream product

• 55-22-1 pyridine-4-carboxylic acid 
• 54109-96-5 diethyl 4-pyridylcarbonylsuccinate 
• 872-85-5 pyridine-4-carbaldehyde 
• 140-88-5 ethyl acrylate 
• 1570-45-2 isonicotinic acid ethylester 
• 123-25-1 succinic acid diethyl ester 

Downstream Products

• 91370-63-7 ethyl 4-(piperidin-4-yl)butyrate 
• 250601-68-4 ethyl 4-{4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]benzyloxyimino}-4-(4-pyridyl)butyrate 

Relevant articles and documents

NEW COMPOUNDS FOR TREATMENT OF DISEASES RELATED TO DUX4 EXPRESSION

The present invention relates to compounds for the treatment of diseases related to DUX4 expression, such as muscular dystrophies. It also relates to use of such compounds, or to methods of use of such compounds.

Studies on non-thiazolidinedione antidiabetic Agents. 2. Novel oxyiminoalkanoic acid derivatives as potent glucose and lipid lowering agents

We previously reported that (Z)-2-{4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl) methoxy]benzyloxyimino}-2-(4-phenoxyphenyl)acetic acid (3) showed potent glucose and lipid lowering effects in genetically obese and diabetic mice, KKA y. This compound a

A new synthesis of rac-nicotine.

-